rs3126085 — FLG

Intronic regulatory variant in the filaggrin gene locus that reduces FLG expression and increases atopic dermatitis (eczema) susceptibility; A allele is markedly more common in East Asian and African populations

See your personal result for FLG

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

Your skin's outermost layer — the stratum corneum — acts as a physical barrier keeping allergens and microbes out while locking moisture in. The protein that holds this barrier together is filaggrin11 filaggrin
from "filament-aggregating protein", encoded by the FLG gene on chromosome 1q21.3. When FLG function is reduced, the skin barrier becomes leaky: water escapes, allergens penetrate, and the immune system is chronically primed for inflammation. rs3126085 is an intronic regulatory variant that influences FLG gene expression — the A allele is associated with reduced filaggrin production and elevated atopic dermatitis (eczema) risk.

rs3126085 sits in an intronic region of FLG-AS1, a non-coding antisense RNA gene adjacent to the FLG coding locus on chromosome 1q21.3. The variant acts as an expression quantitative trait locus (eQTL)22 expression quantitative trait locus (eQTL)
genetic variant that predicts gene expression level: the A allele is associated with a statistically significant reduction in FLG mRNA levels in sun-exposed skin (β = −0.22, p = 3.7×10⁻⁸). Lower filaggrin output means reduced production of the natural moisturizing factor (NMF)33 natural moisturizing factor (NMF)
hygroscopic amino acids released when filaggrin is degraded in the stratum corneum, the molecules that bind water and maintain proper skin acidity. The downstream effects include elevated transepidermal water loss (TEWL), impaired antimicrobial defense, and increased penetration of environmental allergens — the classic triad of atopic dermatitis pathogenesis.

The strongest evidence comes from a GWAS of atopic dermatitis in the Chinese Han population44 GWAS of atopic dermatitis in the Chinese Han population
1,012 cases and 1,362 controls with replication in 3,624 cases and 12,197 controls, which replicated the FLG locus with high confidence (P_combined = 5.90×10⁻¹², OR = 0.82 for the protective G allele). The same study extended findings to a German replication cohort (1,806 cases, 3,256 controls), confirming cross-ethnic relevance. Notably, rs3126085 is in strong linkage disequilibrium with the Chinese FLG null mutation c.3321delA (D′ = 0.976), meaning it partly tags a more penetrant loss-of-function allele; the null mutation itself carries a substantially higher OR (3.37).

A Russian Caucasian population study55 Russian Caucasian population study
women only association; no association in men found the A allele associated with AD with OR = 1.22 in the overall population and OR = 1.69–1.79 in specific genetic models within the female subgroup. This sex-specific signal may reflect hormonal modulation of FLG expression, as estrogen influences keratinocyte differentiation and filaggrin production.

A four-variant interaction study in Chinese Han66 four-variant interaction study in Chinese Han
OR up to 1.79 for A carriers across multiple genetic models showed that rs3126085 interacts epistatically with three other FLG regulatory SNPs (rs12144049, rs471144, rs4363385), with combined genotypes conferring substantially higher AD risk than any single variant alone.

Functional annotation confirms regulatory significance: the A allele shows histone modification marks consistent with enhancer activity and disrupts binding sites for the transcription factors Foxp3 and TEF, both of which influence immune tolerance and skin differentiation pathways.

Carrying the A allele — particularly in the AA homozygous state — indicates a genetically weaker skin barrier with reduced capacity for filaggrin-dependent moisturization. This does not mean you will develop eczema, but it substantially shifts the probability, especially under conditions of environmental challenge (dry climates, harsh detergents, certain fabrics, allergen exposure). The key insight is actionable: a compromised genetic barrier can be compensated with a consistent topical routine targeting the same pathways that filaggrin normally maintains.

Ceramide-containing moisturizers are particularly relevant here. Filaggrin deficiency is associated with ceramide depletion in the stratum corneum, and barrier repair emollients containing the physiologic lipid trio77 barrier repair emollients containing the physiologic lipid trio
ceramide + cholesterol + free fatty acids in approximately equimolar ratio have been shown to normalize barrier function in atopic skin. Bland, fragrance-free cleansers that do not strip ceramides, applied within three minutes of bathing ("soak and seal"), are a cornerstone of guideline-recommended AD prevention.

rs3126085 operates as part of a broader haplotype block in the FLG/HRNR/CRNN locus at 1q21.3, where multiple variants interact. The most clinically significant combination involves concurrent carriage of FLG null alleles such as rs558269137 (2282del4) and rs61816761 (R501X): compound heterozygotes carrying both a null allele and the rs3126085 A allele face near-complete filaggrin deficiency, phenotypically equivalent to homozygous null status. The rs3126085 A allele also interacts with rs12144049, rs471144, and rs4363385 in pairwise and three-way epistatic models (see key references), with combined risk approaching 1.79-fold.

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal Barrier Normal

Standard filaggrin expression — typical skin barrier function

You carry two copies of the G allele at rs3126085, the most common genotype in Europeans (approximately 73% of the European population). This genotype is associated with normal FLG gene expression in skin tissue and does not confer elevated atopic dermatitis susceptibility from this variant alone. Your skin barrier retains its standard capacity to produce the natural moisturizing factors derived from filaggrin degradation.

AA Significantly Reduced Barrier Reduced

Two copies of the reduced-expression allele — notably weaker skin barrier

The FLG locus at 1q21.3 shows strong linkage disequilibrium: rs3126085 AA genotype often co-occurs with other regulatory variants (rs12144049, rs471144, rs4363385) that interact epistatically, with combined odds ratios for AD reaching 1.69–1.79 in the highest-risk haplotype carriers. Additionally, rs3126085 is in partial LD with the Chinese FLG null mutation c.3321delA — if you are of East Asian ancestry, consider whether a comprehensive FLG null allele screen has been performed, as null alleles in the same gene carry substantially higher individual risk (OR 3.37).

The sex-specific signal observed in some studies (stronger association in women) may reflect estrogen's role in modulating keratinocyte filaggrin expression; this is an area of active research.

AG Reduced Barrier Decreased

One copy of the reduced-expression allele — mildly weakened skin barrier

You carry one A allele at rs3126085, which is associated with modestly reduced FLG gene expression in skin. Approximately 41% of the global population shares this heterozygous genotype, though it is more common in East Asian and African populations (where A allele frequencies reach 50–60%). The A allele lowers filaggrin production by roughly 22% in sun-exposed skin, which can translate to modestly elevated transepidermal water loss and a mild increase in atopic dermatitis susceptibility (OR approximately 1.1–1.3 above population baseline). Many AG carriers never develop eczema, but barrier integrity is somewhat more vulnerable under environmental stress — harsh detergents, very dry climates, or frequent wet-work occupations.